BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析

◆英語タイトル:BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1336
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioDelivery Sciences International Inc (BDSI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company that develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.

BioDelivery Sciences International Inc Key Recent Developments

Mar 12,2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
Mar 09,2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
Jan 29,2020: BioDelivery Sciences International, Inc. Expected to Post FY2019 Earnings of $0.08 Per Share …
Jan 13,2020: BDSI expects fourth quarter and 2019 total net sales at the high end of guidance
Jan 06,2020: BioDelivery Sciences appoints Kevin Ostrander as Senior Vice President of Business Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioDelivery Sciences International Inc – Key Facts
BioDelivery Sciences International Inc – Key Employees
BioDelivery Sciences International Inc – Key Employee Biographies
BioDelivery Sciences International Inc – Major Products and Services
BioDelivery Sciences International Inc – History
BioDelivery Sciences International Inc – Company Statement
BioDelivery Sciences International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioDelivery Sciences International Inc – Business Description
Business Segment: Contract Revenue
Overview
Performance
Business Segment: Product Royalty Revenue
Overview
Performance
Business Segment: Product Sales
Overview
Performance
Business Segment: Research and Development Reimbursements
Performance
BioDelivery Sciences International Inc – Corporate Strategy
BioDelivery Sciences International Inc – SWOT Analysis
SWOT Analysis – Overview
BioDelivery Sciences International Inc – Strengths
BioDelivery Sciences International Inc – Weaknesses
BioDelivery Sciences International Inc – Opportunities
BioDelivery Sciences International Inc – Threats
BioDelivery Sciences International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioDelivery Sciences International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
Mar 09, 2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
Jan 13, 2020: BDSI expects fourth quarter and 2019 total net sales at the high end of guidance
Jan 06, 2020: BioDelivery Sciences appoints Kevin Ostrander as Senior Vice President of Business Development
Nov 25, 2019: BioDelivery Sciences appoints Dr. Vanila Singh, former Chief Medical Officer of Health and Human Services, to its Board of Directors
Nov 12, 2019: BioDelivery Sciences reports strong third quarter results, raises full year 2019 and provides 2020 net sales expectations
Aug 08, 2019: BioDelivery Sciences reports strong second quarter 2019 results and raises net sales expectations
May 28, 2019: BioDelivery Sciences strengthens financial position with debt refinancing
May 06, 2019: BioDelivery Sciences reports strong first quarter 2019 results and raises BELBUCA full-year expectations
Mar 14, 2019: BioDelivery Sciences reports strong 2018 results and 2019 expectations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioDelivery Sciences International Inc, Key Facts
BioDelivery Sciences International Inc, Key Employees
BioDelivery Sciences International Inc, Key Employee Biographies
BioDelivery Sciences International Inc, Major Products and Services
BioDelivery Sciences International Inc, History
BioDelivery Sciences International Inc, Subsidiaries
BioDelivery Sciences International Inc, Key Competitors
BioDelivery Sciences International Inc, Ratios based on current share price
BioDelivery Sciences International Inc, Annual Ratios
BioDelivery Sciences International Inc, Annual Ratios (Cont...1)
BioDelivery Sciences International Inc, Interim Ratios
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioDelivery Sciences International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
BioDelivery Sciences International Inc, Performance Chart (2015 - 2019)
BioDelivery Sciences International Inc, Ratio Charts
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vector Group Ltd.:企業の戦略・SWOT・財務情報
    Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Banco Santander SA:戦略・SWOT・企業財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • British Columbia Cancer Agency:製薬・医療:M&Aディール及び事業提携情報
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as diagnostic and therapy planning, radiation therapy, patient assessment …
  • National Gypsum Co:企業の戦略・SWOT・財務情報
    National Gypsum Co - Strategy, SWOT and Corporate Finance Report Summary National Gypsum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Expro Holdings UK 3 Ltd:企業の戦略的SWOT分析
    Expro Holdings UK 3 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Phoenix Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Check Point Software Technologies Ltd (CHKP):企業の財務・戦略的SWOT分析
    Check Point Software Technologies Ltd (CHKP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • AMC Entertainment Holdings, Inc.:企業のM&A・事業提携・投資動向
    AMC Entertainment Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AMC Entertainment Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Exco Resources Inc (XCOOQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, and production of onshore natural gas and oil assets. It provides services such as portfolio re …
  • Lonestar Resources US Inc (LONE):企業の財務・戦略的SWOT分析
    Lonestar Resources US Inc (LONE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Halcon Resources Corp (HK):石油・ガス:M&Aディール及び事業提携情報
    Summary Halcon Resources Corp (Halcon) is an independent energy company that acquires, explores, produces, and develops onshore liquids-rich assets. The company owns and operates its oil and gas explorates resources in El Halcon of Eagle Ford shale formation and Bakken and Three Forks formations. It …
  • Indianapolis Power & Light Co:発電所・企業SWOT分析
    Indianapolis Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • American Cruise Lines, Inc.:企業の戦略・SWOT・財務情報
    American Cruise Lines, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Cruise Lines, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • National Savings and Investments (NS&I):企業の戦略・SWOT・財務情報
    National Savings and Investments (NS&I) - Strategy, SWOT and Corporate Finance Report Summary National Savings and Investments (NS&I) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Maxim Integrated Products Inc (MXIM):企業の財務・戦略的SWOT分析
    Maxim Integrated Products Inc (MXIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Moberg Pharma AB (MOB):医療機器:M&Aディール及び事業提携情報
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged …
  • TClarke Plc (CTO):企業の財務・戦略的SWOT分析
    TClarke Plc (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Standard Life plc:企業のM&A・事業提携・投資動向
    Standard Life plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Standard Life plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Intuitive Surgical Inc (ISRG)-医療機器分野:企業M&A・提携分析
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆